Cargando…
Reasons for stopping Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC): A retrospective study to improve future patient selection
To improve the prognosis and maintain quality of life in patients with peritoneal metastasis (PM), a novel treatment has been introduced–pressurized intraperitoneal aerosol chemotherapy (PIPAC). The majority of teams propose at least 3 PIPAC procedures. However, for many patients PIPAC is stopped af...
Autores principales: | Ezanno, Anne-Cécile, Malgras, Brice, Conan, Pierre-Louis, Aime, Adeline, Fawaz, Jade, Picchi, Hugo, Doat, Solène, Pocard, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688840/ https://www.ncbi.nlm.nih.gov/pubmed/38033087 http://dx.doi.org/10.1371/journal.pone.0287785 |
Ejemplares similares
-
A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC)
por: Ezanno, Anne-Cecile, et al.
Publicado: (2022) -
Pressurized intraperitoneal aerosol chemotherapy, reasons for interrupting treatment: a systematic review of the literature
por: Ezanno, Anne-Cecile, et al.
Publicado: (2023) -
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) as an outpatient procedure
por: Graversen, Martin, et al.
Publicado: (2018) -
PIPAC EstoK 01: Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study
por: Eveno, Clarisse, et al.
Publicado: (2018) -
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for the treatment of malignant mesothelioma
por: Giger-Pabst, Urs, et al.
Publicado: (2018)